183 related articles for article (PubMed ID: 30487131)
1. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
[TBL] [Abstract][Full Text] [Related]
2. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
3. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
4. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
[TBL] [Abstract][Full Text] [Related]
5. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
[TBL] [Abstract][Full Text] [Related]
6. Exploring Differences in the Aspirin-Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Monroe KR; Haiman CA; Marchand LL
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):162-169. PubMed ID: 27765797
[TBL] [Abstract][Full Text] [Related]
7. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
[TBL] [Abstract][Full Text] [Related]
8. Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study.
Mondul AM; Joshu CE; Barber JR; Prizment AE; Bhavsar NA; Selvin E; Folsom AR; Platz EA
Cancer Prev Res (Phila); 2018 Dec; 11(12):779-788. PubMed ID: 30327368
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
10. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
[TBL] [Abstract][Full Text] [Related]
11. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
12. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
Murad AS; Down L; Davey Smith G; Donovan JL; Athene Lane J; Hamdy FC; Neal DE; Martin RM
Int J Cancer; 2011 Mar; 128(6):1442-8. PubMed ID: 20506261
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
[TBL] [Abstract][Full Text] [Related]
15. The use of aspirin and the risk of mortality in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
J Urol; 2015 Apr; 193(4):1220-5. PubMed ID: 25463991
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
[TBL] [Abstract][Full Text] [Related]
17. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Downer MK; Allard CB; Preston MA; Wilson KM; Kenfield SA; Chan JM; Mucci LA; Giovannucci E; Stampfer MJ
Eur Urol Oncol; 2019 Mar; 2(2):126-134. PubMed ID: 31017087
[TBL] [Abstract][Full Text] [Related]
19. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
[TBL] [Abstract][Full Text] [Related]
20. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
Vidal AC; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Clin Cancer Res; 2015 Feb; 21(4):756-62. PubMed ID: 25520389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
